{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:36:24Z","timestamp":1793702184822,"version":"4.5.1"},"reference-count":43,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"crossref","award":["Abbott-Dc-2019-03"],"award-info":[{"award-number":["Abbott-Dc-2019-03"]}],"id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2020,5,26]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Compare cost of the interstitial liquid glucose flash monitoring (FM) system (FreeStyle Libre 2) versus self-monitoring of blood glucose (SMBG) in adults with type 1 diabetes mellitus (T1DM) in Spain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>A model was developed to estimate, with the perspective of the Spanish health system, the annual costs associated with glucose monitoring and hypoglycemic events management in T1DM population, with multiple insulin daily doses (MDI). According to published evidence, rate of severe hypoglycemia (SHE) of 4.90 episodes per patient-year was applied. Reduction of SHE (58.6%) was modeled associated with FM use. Published rates of hospital care (20.2%) and subsequent admission (16%) were assumed for SHE. The daily consumption of strips and lancets was 9 in patients with SMBG (before and after 4 daily intakes and at bedtime) and 0.5 for FM users (according to IMPACT trial findings). Annual consumption of 26 FM sensors was considered (1 every 14 days). Unit costs (in \u20ac of 2019, excluding VAT) were obtained from literature and national databases. Sensitivity analyses (SA) were carried out to evaluate the model robustness.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The total annual cost\/patient was \u20ac4437 for SMBG and \u20ac2526 for FM. The use of FM would be associated with an annual savings in the costs of monitoring and managing hypoglycemic events of \u20ac1911 per patient-year. In a hypothetical cohort of 1000 patients with T1DM MDI, FM could avoid in 1 year 4900 SHE, 93 hospitalizations for SHE. In addition, the use of FM would generate total savings of up to \u20ac1 910 000 per year. In the SA with alternative hypoglycemia events rates and use of strips and lancets, and including non-SHE episodes, savings from \u20ac370 000 to \u20ac1 760 000 were observed with FM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The use of the FM system to monitor glucose in adults with T1DM treated with MDI, would reduce hypoglycemic events and would result in cost savings for the health system.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2020-001330","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T06:40:08Z","timestamp":1595400008000},"page":"e001330","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":31,"title":["Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3047-6152","authenticated-orcid":false,"given":"Itziar","family":"Oyag\u00fcez","sequence":"first","affiliation":[{"name":"Pharmacoeconomics & Outcomes Research Iberia, Pozuelo de Alarcon, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0191-4504","authenticated-orcid":false,"given":"Juan Francisco","family":"Merino-Torres","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universitat de Val\u00e8ncia Facultat de Medicina i Odontologia, Valencia, Comunitat Valenciana, Spain"},{"name":"Endocrinology and Nutrition, La Fe University and Polytechnic Hospital, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Brito","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition, Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Bellido","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition, Cruces University Hospital, Barakaldo, Pa\u00eds Vasco, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roque","family":"Cardona-Hernandez","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Hospital Sant Joan de Deu, Barcelona, Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gomez-Peralta","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Morales-Perez","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, University Hospital Complex Badajoz, Badajoz, Extremadura, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"2025073112444685000_8.1.e001330.1","doi-asserted-by":"crossref","unstructured":"Lovic D , Piperidou A , Zografou I , et al . The growing epidemic of diabetes mellitus. Curr Vasc Pharmacol 2019.","DOI":"10.2174\/1570161117666190405165911"},{"key":"2025073112444685000_8.1.e001330.2","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8603-9-17","article-title":"Costs, outcomes and challenges for diabetes care in Spain","volume":"9","author":"Lopez-Bastida","year":"2013","journal-title":"Global Health"},{"key":"2025073112444685000_8.1.e001330.3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1575-0922(09)73510-7","article-title":"Gu\u00edas cl\u00ednicas en diabetes mellitus tipo 1","volume":"56","author":"Escobar-Jim\u00e9nez","year":"2009","journal-title":"Endocrinolog\u00eda y Nutrici\u00f3n"},{"key":"2025073112444685000_8.1.e001330.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003795"},{"key":"2025073112444685000_8.1.e001330.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.02.001"},{"key":"2025073112444685000_8.1.e001330.6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1575-0922(08)75840-6","article-title":"\u00bfEs posible alcanzar en La pr\u00e1ctica cl\u00ednica Los objetivos de control metab\u00f3lico establecidos para pacientes Con diabetes mellitus tipo 1","volume":"55","author":"Baena","year":"2008","journal-title":"Endocrinolog\u00eda y Nutrici\u00f3n"},{"key":"2025073112444685000_8.1.e001330.7","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s13300-018-0515-0","article-title":"The trend of high-dose insulin usage among patients with diabetes in the UK: a retrospective study","volume":"9","author":"Idris","year":"2018","journal-title":"Diabetes Ther"},{"key":"2025073112444685000_8.1.e001330.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2009.04.022"},{"key":"2025073112444685000_8.1.e001330.9","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2073"},{"key":"2025073112444685000_8.1.e001330.10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.avdiab.2012.01.002","article-title":"Recomendaciones 2012 de la Sociedad Espa\u00f1ola de diabetes sobre La utilizaci\u00f3n de tiras reactivas para La medici\u00f3n de la glucemia capilar en personas Con diabetes","volume":"28","author":"Men\u00e9ndez Torre","year":"2012","journal-title":"Avances en Diabetolog\u00eda"},{"key":"2025073112444685000_8.1.e001330.11","unstructured":"National Institute for Health and Care Excellence . Type 1 diabetes in adults: diagnosis and management Disponible en:acceso agosto 2019. Available: https:\/\/www.nice.org.uk\/guidance\/ng17 [Accessed Jun 2017]."},{"key":"2025073112444685000_8.1.e001330.12","doi-asserted-by":"publisher","DOI":"10.1177\/014572170403000119"},{"key":"2025073112444685000_8.1.e001330.13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.endinu.2017.10.005","article-title":"Factors associated to adherence to blood glucose self-monitoring in patients with diabetes treated with insulin. The dapa study","volume":"65","author":"Vidal Flor","year":"2018","journal-title":"Endocrinol Diabetes Nutr"},{"key":"2025073112444685000_8.1.e001330.14","unstructured":"Ministerio de Sanidad, Consumo Y Bienestar social . Nota de prensa. Ministerio Y CC.AA. Han aprobado El plan de Abordaje de Terapias Avanzadas Y La priorizaci\u00f3n de cinco colectivos para La inclusi\u00f3n del sistema flash de monitorizaci\u00f3n de glucosa para adultos Con diabetes tipo1. Disponible en, 2019. Available: https:\/\/www.mscbs.gob.es\/gabinete\/notasPrensa.do?id=4430"},{"key":"2025073112444685000_8.1.e001330.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31535-5"},{"key":"2025073112444685000_8.1.e001330.16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00125-017-4527-5","article-title":"Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the impact randomised controlled trial","volume":"61","author":"Oskarsson","year":"2018","journal-title":"Diabetologia"},{"key":"2025073112444685000_8.1.e001330.17","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-016-0223-6"},{"key":"2025073112444685000_8.1.e001330.18","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2480"},{"key":"2025073112444685000_8.1.e001330.19","doi-asserted-by":"crossref","first-page":"517.e1","DOI":"10.1016\/j.endonu.2013.04.005","article-title":"Grupo de trabajo de diabetes mellitus de la Sociedad Espa\u00f1ola de Endocrinolog\u00eda Y Nutrici\u00f3n (seen). Documento de posicionamiento: evaluaci\u00f3n Y manejo de la hipoglucemia en El paciente Con diabetes mellitus. Grupo de Trabajo de diabetes mellitus de la Sociedad Espa\u00f1ola de Endocrinolog\u00eda Y Nutrici\u00f3n","volume":"60","author":"Mezquita-Raya","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"2025073112444685000_8.1.e001330.20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/dom.12689","article-title":"Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study","volume":"18","author":"Khunti","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"2025073112444685000_8.1.e001330.21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-016-4146-6","article-title":"Glucose concentrations of less than 3.0 mmol\/l (54 mg\/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"60","year":"2017","journal-title":"Diabetologia"},{"key":"2025073112444685000_8.1.e001330.22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3111\/13696990903310501","article-title":"Management of severe hypoglycaemia: cultural similarities, differences and resource consumption in three European countries","volume":"12","author":"Lammert","year":"2009","journal-title":"J Med Econ"},{"key":"2025073112444685000_8.1.e001330.23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.avdiab.2013.07.007","article-title":"Costes directos de la diabetes mellitus Y de Sus complicaciones en Espa\u00f1a (estudio SECCAID: Spain estimated cost Ciberdem-Cabimer in diabetes)","volume":"29","author":"Crespo","year":"2013","journal-title":"Avances en Diabetolog\u00eda"},{"key":"2025073112444685000_8.1.e001330.24","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/dme.12843","article-title":"Incidence and care-related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project","volume":"32","author":"Barranco","year":"2015","journal-title":"Diabet Med"},{"key":"2025073112444685000_8.1.e001330.25","doi-asserted-by":"publisher","DOI":"10.3111\/13696990903336597"},{"key":"2025073112444685000_8.1.e001330.26","doi-asserted-by":"crossref","DOI":"10.1111\/dme.13662","article-title":"Regional variations in definitions and rates of hypoglycaemia: findings from the global HAT observational study of 27 585 people with type 1 and insulin-treated type 2 diabetes mellitus","author":"Khunti","year":"2018","journal-title":"Diabet Med"},{"key":"2025073112444685000_8.1.e001330.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0599-y"},{"key":"2025073112444685000_8.1.e001330.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126427","article-title":"Prevalence and incidence of hypoglycaemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies","volume":"10","author":"Edridge","year":"2015","journal-title":"PLoS One"},{"key":"2025073112444685000_8.1.e001330.29","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-014-0057-z"},{"key":"2025073112444685000_8.1.e001330.30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s13300-017-0285-0","article-title":"The economic burden of insulin-related hypoglycemia in Spain","volume":"8","author":"Parekh","year":"2017","journal-title":"Diabetes Ther"},{"key":"2025073112444685000_8.1.e001330.31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.diabres.2018.01.028","article-title":"Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment","volume":"138","author":"Hellmund","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2025073112444685000_8.1.e001330.32","first-page":"86","article-title":"Cost Calculation for a Flash Glucose Monitoring System for Adults with Type 2 Diabetes Mellitus Using Intensive Insulin - a UK Perspective","volume":"14","author":"Hellmund","year":"2018","journal-title":"Eur Endocrinol"},{"key":"2025073112444685000_8.1.e001330.33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dia.2018.0362","article-title":"The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set","volume":"21","author":"Beck","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2025073112444685000_8.1.e001330.34","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1770"},{"key":"2025073112444685000_8.1.e001330.35","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2005.7.612"},{"key":"2025073112444685000_8.1.e001330.36","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199704)14:4<321::AID-DIA356>3.0.CO;2-H"},{"key":"2025073112444685000_8.1.e001330.37","unstructured":"Rittmeyer D , Schmid C , Haug C , et al . A novel glucose monitoring system versus a conventional SMBG system: time and step analysis. Paris, France: Poster ATTD-0466. 8th International Conference on Advanced Technologies & Treatments for Diabetes, 18\u201321 February 2015."},{"key":"2025073112444685000_8.1.e001330.38","first-page":"73","article-title":"Cost-Effectiveness analysis of a flash glucose monitoring system for patients with type 1 diabetes receiving intensive insulin treatment in Sweden","volume":"14","author":"Bilir","year":"2018","journal-title":"Eur Endocrinol"},{"key":"2025073112444685000_8.1.e001330.39","first-page":"30295","article-title":"An\u00e1lisis de coste-efectividad de control gluc\u00e9mico con FreeStyle Libre\u00ae en pacientes diab\u00e9ticos tipo 1 en atenci\u00f3n primaria de salud de Burgos. [Cost-effectiveness analysis of glycaemic control of a glucose monitoring system (FreeStyle Libre\u00ae) for patients with type 1 diabetes in primary health care of Burgos]","volume":"8621","author":"Gil-Ib\u00e1\u00f1ez","year":"2019","journal-title":"Enferm Clin"},{"key":"2025073112444685000_8.1.e001330.40","doi-asserted-by":"crossref","first-page":"A585","DOI":"10.1016\/j.jval.2017.08.1056","article-title":"Economic Evaluation of Flash Glucose Monitoring Compared To Self - Monitoring of Blood Glucose For The Management of Patients Receiving Intensive Insulin With Diabetes Type 1 And Type 2 In Greece","volume":"20","author":"Vellopoulou","year":"2017","journal-title":"Value in Health"},{"key":"2025073112444685000_8.1.e001330.41","first-page":"A","article-title":"Cost effectiveness analysis of a flash continuous glucose monitoring system for type 2 diabetes (T2DM) patients receiving intensive insulin treatment in the UK [Abstract]","volume":"20","author":"Wehler","year":"2017","journal-title":"Value Health"},{"key":"2025073112444685000_8.1.e001330.42","doi-asserted-by":"crossref","first-page":"A698","DOI":"10.1016\/j.jval.2016.09.2016","article-title":"Cost effectiveness analysis of a flash glucose monitoring system for type 2 diabetes (T2DM) patients receiving intensive insulin treatment in Europe","volume":"19","author":"Li","year":"2016","journal-title":"Value in Health"},{"key":"2025073112444685000_8.1.e001330.43","doi-asserted-by":"crossref","first-page":"A351","DOI":"10.1016\/j.jval.2014.08.730","article-title":"Cost effectiveness analysis of flash glucose monitoring for type 2 diabetes patients receiving insulin treatment in the UK","volume":"17","author":"Li","year":"2014","journal-title":"Value in Health"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2020-001330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:44:58Z","timestamp":1753991098000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2020-001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,7,21]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/bmjdrc-2020-001330"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2020-001330","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}